76 – 90 of 95
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Bacterial killing by heparin-binding peptides from PRELP and thrombospondin
(
- Contribution to journal › Article
-
Mark
Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor.
(
- Contribution to journal › Article
- 2005
-
Mark
Domain 5 of high molecular weight kininogen is antibacterial.
(
- Contribution to journal › Article
- 2004
-
Mark
Activation of the complement system generates antibacterial peptides.
(
- Contribution to journal › Article
-
Mark
Antimicrobial activities of heparin-binding peptides.
(
- Contribution to journal › Article
- 2003
-
Mark
Heme-Scavenging Role of alpha1-Microglobulin in Chronic Ulcers.
(
- Contribution to journal › Article
-
Mark
Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells.
(
- Contribution to journal › Article
- 2002
-
Mark
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37
(
- Contribution to journal › Article
- 2001
-
Mark
Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin
(
- Contribution to journal › Article
-
Mark
Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers
(
- Contribution to journal › Article
-
Mark
Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers
(
- Contribution to journal › Article
- 2000
-
Mark
Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers
(
- Contribution to journal › Article
- 1999
-
Mark
Chronic ulcers: a method for sampling and analysis of wound fluid
(
- Contribution to journal › Article
- 1996
-
Mark
The molecular basis of Sanfilippo syndrome type B
(
- Contribution to journal › Article
-
Mark
Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I
(
- Contribution to journal › Article